Type: research

Recent polling indicates a significant decline in President Trump's approval ratings among key voter demographics, which could pose challenges for Republican candidates in the upcoming midterm elections. This shift highlights potential vulnerabilities in Trump's coalition that helped him secure the presidency in 2024.

The financial burden of caregiving is becoming a significant issue for many Americans, influencing voter preferences ahead of the 2026 midterm elections. A recent AARP survey indicates that candidates supporting policies for unpaid caregivers could gain crucial support from older voters, a key demographic in upcoming elections.

Pension systems worldwide are facing a significant demographic crisis due to longer life expectancies and declining birth rates, which threaten their ability to provide sustainable retirement benefits for future generations. This situation is prompting pension funds to reconsider their investment strategies and risk profiles.

A recent CNBC poll reveals significant fears among voters regarding the potential outcomes of the upcoming midterm elections, highlighting concerns about extreme policy shifts and economic management depending on which party controls Congress. This polarization could impact voter behavior and party strategies moving forward.

Amgen's drug Imdelltra, when combined with AstraZeneca's Imfinzi, has shown promising results in extending survival for patients with extensive-stage small cell lung cancer, reducing the risk of death by 58%. This breakthrough could significantly change treatment protocols and enhance commercial prospects for Amgen's drug.

Victor Haghani, founder of Elm Wealth, suggests that retail investors may be better off investing in broad market index funds rather than attempting to pick individual stocks or complex ETFs, as they may lack the sophistication to outperform the market.

The AI infrastructure sector is experiencing significant turmoil, with major players like Neoclouds facing steep declines and SK Hynix canceling its IPO due to market volatility. This situation raises concerns about the sustainability of investments in AI technologies and their returns.

The S&P 500 is currently facing challenges in breaking above the 7,800 level, raising concerns about a potential bearish trend similar to past market corrections. Investors should be cautious as repeated failures to sustain bullish patterns could lead to a significant decline.

The recent Phase 3 trial results for Moderna and Merck's personalized cancer vaccine indicate a significant advancement in melanoma treatment, despite a sharp stock sell-off that reflects investor skepticism about its commercial viability. Oncologists view the data as a potential breakthrough that could reshape standard care for melanoma patients post-surgery.

The transition of leadership in family offices to younger generations is expected to significantly alter investment strategies, with a greater emphasis on debt, alternative investments, and new philanthropic priorities, potentially reshaping the management of over $5 trillion in assets.